Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CRDF
$1.10
+3.30%
CRDF
· Cardiff Oncology, Inc.
$1.10
+0.04 (+3.30%)
At close · Oct 9
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has performed an analysis and concluded that there exists a substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$82.85M
Shares
77.80M
Volume · Oct 9
79.53K
Avg daily vol (3M)
1.05M
All webcasts
Earnings call · FY2022 Q3
Cardiff Oncology, Inc. (CRDF) Q3 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$93,000
+8.1% YoY
Diluted EPS
-$0.20
Net income
-$8.57M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 3, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 3, 2022 · complete as-filed document